Nucleotide excision repair deficiency in melanoma in response to UVA
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The causative link between UV exposure and melanoma development is well known, however the mechanistic relationship remains incompletely characterised. UVA and UVB components of sunlight are implicated in melanomagenesis; however the majority of studies have focused on the effects of UVB and UVC light. Interestingly, melanoma tumour sequencing has revealed an overrepresentation of mutations signature of unrepaired UV-induced DNA damage. Repair of UVA-induced DNA damage is thought to occur primarily through the Nucleotide Excision Repair (NER) pathway, which recognises and repairs damage either coupled to transcription (Transcription Coupled Repair; TCR), or through global genome scanning (Global Genome Repair; GGR). Current literature suggests NER is deficient in melanoma, however the cause of this remains unknown; and whether reduced NER activity in response to UVA may be involved in melanoma development remains uncharacterised. In this study we aimed to determine if melanoma cells exhibit reduced levels of NER activity in response to UVA. METHODS: Melanocyte and melanoma cell lines were UVA-irradiated, and DNA damage levels assessed by immunodetection of Cyclobutane Pyrimidine Dimer (CPD) and (6-4) Photoproduct [(6-4)PP] lesions. Expression of NER pathway components and p53 following UVA treatment was quantified by qPCR and western blot. RESULTS: UVA did not induce detectable induction of (6-4)PP lesions, consistent with previous studies. Repair of CPDs induced by UVA was initiated at 4 h and complete within 48 h in normal melanocytes, whereas repair initiation was delayed to 24 h and >40 % of lesions remained in melanoma cell lines at 48 h. This was coupled with a delayed and reduced induction of GGR component XPC in melanoma cells, independent of p53. CONCLUSION: These findings support that NER activity is reduced in melanoma cells due to deficient GGR. Further investigation into the role of NER in UVA-induced melanomagenesis is warranted and may have implications for melanoma treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“UVA similarly lowered XPC expression in melanoma cells, and they also show impaired repair of UVA-induced CPDs relative to normal melanocytes58.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [58]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939 · cited 1×
“The NER pathway possesses two different mechanisms for detection of DNA damage; Transcription Coupled Repair (TCR) and Global Genome Repair (GGR; for extensive review, see [29–32]).”
BackgroundInhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103 · cited 1×
“Targeted therapies to the BRAF V600E mutation present in 30–60 % of metastatic melanomas [4, 5] and immunetherapy based approaches display the highest treatment response rates [6, 7].”
BackgroundPatterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Flaherty, K. T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M., Demidov, L. V., Hassel, J. C., Rutkowski, P., Mohr, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203421 · Cited by 2,160 · cited 1×
“Targeted therapies to the BRAF V600E mutation present in 30–60 % of metastatic melanomas [4, 5] and immunetherapy based approaches display the highest treatment response rates [6, 7].”
BackgroundLandon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
A comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group
Flaherty, K. T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M. M., Демидов, Л. В., Hassel, J. C., Rutkowski, P. L., Mohr, P., et al. (2012) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-63198 · Cited by 1,330
Understanding nucleotide excision repair and its roles in cancer and ageing
Marteijn, J. A., Lans, H., Vermeulen, W., & Hoeijmakers, J. H. J. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3822 · Cited by 1,192 · cited 1×
“The NER pathway possesses two different mechanisms for detection of DNA damage; Transcription Coupled Repair (TCR) and Global Genome Repair (GGR; for extensive review, see [29–32]).”
BackgroundIchihashi, M., Ueda, M., Budiyanto, A., Bito, T., Oka, M., Fukunaga, M., Tsuru, K., & Horikawa, T. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00150-1 · Cited by 952
A review of human carcinogens--part D: radiation
El Ghissassi, F., Baan, R., Straif, K., Grosse, Y., Secretan, B., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70213-x · Cited by 900 · cited 1×
“The International Agency for Research in Cancer (IARC) now recognises UVA as a class I carcinogen [23].”
Background
Research works printed but not linked: 2
- Stoyanova T Roy N Kopanja D Bagchi S Raychaudhuri P DDB2 decides cell fate following DNA damage Proc Natl Acad Sci USA 2009 106 26 10690 10695 10.1073/pnas.0812254106 19541625 PMC2705559 · DOI · Paper page
- Bowden NA Ashton KA AveryKiejda KA Zhang XD Hersey P Scott RJ Nucleotide excision repair gene expression after cisplation treatment in melanoma Cancer Res. 2010 70 7905 7917 10.1158/0008-5472.CAN-10-0161 20807809 · DOI
Cited by
Mechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
United Nations Environment Programme, E. E. A. P. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp90033a · Cited by 240
Roles of UVA radiation and DNA damage responses in melanoma pathogenesis
Khan, A. Q., Travers, J. B., & Kemp, M. G. (2018) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22176 · Cited by 152
“Interestingly, this finding was supported by additional studies using UVA or UVB light sources (instead of UVC), in which melanoma cells showed a reduced ability to remove UV-induced CPDs from genomic DNA in comparison to normal melanocytes [Budden et al., 2016; Murray et al., 2016].”
BackgroundResultUVA Radiation, DNA Damage, and Melanoma
Jin, S., Padron, F., & Pfeifer, G. P. (2022) · ACS Omega · doi:10.1021/acsomega.2c04424 · Cited by 99
Ultraviolet (UV) radiation: a double-edged sword in cancer development and therapy
Yu, Z.-W., Zheng, M. H., Fan, H., Liang, X., & Tang, Y. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00209-8 · Cited by 97
“While ROS can indeed damage DNA, an effect that should not be ignored is the oxidation of critical intracellular proteins including nucleotide excision repair (NER) proteins, thereby increasing the possibility of mutations in genetic materials caused by UVB [82–84].”
Background
Metadata
- Authors
- Murray, H. C., Maltby, V. E., Smith, D. W., & Bowden, N. A.
- Affiliations
- Hunter Medical Research Institute (AU)
- Corresponding author
- Bowden, Nikola A.
- Venue
- Experimental Hematology & Oncology
- Published
- 2015-12
- Volume
- 5
- Issue
- 1
- Pages
- 6-6
- ISSN
- 2162-3619 (ISSN-L)
- PMC
- PMC4765239
- OpenAlex
- W2287099773
- Cited by
- 28
- References
- 63
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 2 · 2022: 5 · 2020: 1 · 2019: 3 · 2018: 5 · 2017: 2 · 2016: 2
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Experimental Hematology and Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- NOVA (University of Newcastle Australia) (submittedVersion, cc-by)
- Funders
- Cure Cancer Australia Foundation
- Cancer Australia
- National Health and Medical Research Council (AU)
- Cancer Institute NSW
- Canadian Institutes of Health Research (CA)
- Multiple Sclerosis Research Australia (AU)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Dermatology › Skin Protection and Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- nucleotide excision repair, melanoma, UVA, global genome repair, transcription-coupled repair, cyclobutane pyrimidine dimers, 6-4 photoproducts, XPC, p53, UV-induced DNA damage, melanomagenesis, melanocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nucleotide excision repair deficiency in melanoma in response to UVA. https://app.cochat.ai/papers/10.1186/s40164-016-0035-4
- The paper
- Murray, H. C., Maltby, V. E., Smith, D. W., & Bowden, N. A. (2015). Nucleotide excision repair deficiency in melanoma in response to UVA. Experimental Hematology & Oncology. https://doi.org/10.1186/s40164-016-0035-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.